Atlas FDA

ABBOTT REALTIME HBV ASSAY

FDA premarket approval P080026/S017 · decided 2016-04-12

Approval details

PMA number
P080026
Supplement
S017
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ABBOTT REALTIME HBV ASSAY
Generic name
Hepatitis Viral B DNA Detection
Applicant
Abbott Molecular, Inc.
Date received
2016-03-28
Decision date
2016-04-12
Days to decision
15 days
Decision code
OK30
Product code
MKT
Advisory committee
Microbiology
Expedited review
No
Location
Des Plaines, IL
Statement
Change to consolidate the current QC testing for the Amplification Reagent Kit from two stages into a single finished kit QC stage.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Alinity m HCV (K252102)Abbott Molecular, Inc.2025-09-25
Alinity m EBV (09N43-095) (K243489)Abbott Molecular, Inc.2025-07-28
Alinity m CMV (K243485)Abbott Molecular, Inc.2025-07-01
Alinity m BKV (K241921)Abbott Molecular, Inc.2025-03-24
Alinity m Resp-4-Plex (K241573)Abbott Molecular, Inc.2025-02-14
Alinity m HSV 1 & 2 / VZV (K233349)Abbott Molecular, Inc.2024-05-03
Alinity m STI Assay (K222379)Abbott Molecular, Inc.2023-03-03
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075) (K212778)Abbott Molecular, Inc.2022-07-15